Carbapenem-resistant hypervirulent P. aeruginosa coexpressing exoS/exoU in Brazil

Sergio M Morgado1, Nathália M S Bighi1, Fernanda S Freitas1

  • 1Laboratório de Genética Molecular de Microrganismos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.

Abstract

Insights

This study found rare carbapenem-resistant Pseudomonas aeruginosa strains in Brazil co-expressing the hypervirulent toxins ExoS and ExoU. These strains exhibit high toxin expression, indicating potential clinical significance.

Area of Science:

  • Microbiology
  • Genomics
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a clinically significant bacterium known for antibiotic resistance.
  • The type III secretion system (T3SS) and its toxins ExoS and ExoU are key virulence factors.
  • Co-expression of ExoS and ExoU is linked to hypervirulence, but poorly understood.

Purpose of the Study:

  • To characterize a carbapenem-resistant Pseudomonas aeruginosa strain from Brazil with the exoU+/exoS+ genotype.
  • To investigate the expression and genetic context of exoU and exoS in this strain.

Main Methods:

  • Antibiotic susceptibility testing and whole-genome sequencing of 33 P. aeruginosa isolates from Brazil.
  • Phylogenetic analysis, resistome and virulome characterization.
  • Quantitative PCR (qPCR) to evaluate exoU/exoS expression and analysis of the exoU genomic region.

Main Results:

  • A carbapenem-resistant strain (serotype O4, ST4996) with exoU+/exoS+ genotype was identified.
  • The strain possessed OprD porin mutations but lacked carbapenemases.
  • qPCR revealed higher co-expression of exoU and exoS compared to controls, with exoU integrated into the PAPI-2 island.

Conclusions:

  • Pseudomonas aeruginosa strains co-harboring exoS and exoU are rare in Brazil but can be associated with carbapenem resistance.
  • The identified Brazilian strain demonstrated comparable exoS/exoU expression levels to hypervirulent Chinese strains, despite belonging to a different sequence type (ST).

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...